BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in PCRX — Pacira BioSciences, Inc.
CIK 1520354
Paris, I0
Position in PCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,822,741
+$158,338 QoQ
Shares Held
111,263
-5.6% QoQ
Ownership
0.279%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 254 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $480,515,408 across 25 Drug Manufacturers - Specialty & Generic names. PCRX ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
1,494,259 | $251,842,409 | |
| 2 | ZTS |
Zoetis Inc.
|
1,173,974 | $84,361,770 | |
| 3 | ALKS |
Alkermes plc.
|
1,159,216 | $60,742,916 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
976,103 | $33,070,368 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
44,851 | $24,301,615 | |
| 6 | VTRS |
Viatris Inc
|
828,396 | $13,154,927 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
94,458 | $3,875,610 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
72,383 | $3,421,543 |
All Filings in PCRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,822,741 | 111,263 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,664,403 | 117,894 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,048,533 | 117,795 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $10,978 | 426 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $10,181 | 426 | Shares | Defined | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||